Clinical Trials Directory

Trials / Completed

CompletedNCT03498157

IMpact of PRehabilitation in Oncology Via Exercise - Breast Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Milton S. Hershey Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether patients are able to participate in a so called prehabilitation program (prior to the beginning of cancer treatment) which includes (1) a supervised and home-based exercise program plus one educational session or (2) just home-based exercise plus one educational session or (3) just one educational session. Breast cancer surgery may have potential for several side effects, including functional (e.g. flexibility in the affected arm, lymphedema \[swelling that generally occurs in the arms or legs that occurs as a result of the removal of or damage to lymph nodes as a part of cancer treatment\], shoulder pain) and psychosocial (e.g. reduced quality of life, increased fatigue) aspects. Evidence shows that exercise is considered to be an effective treatment approach in breast cancer patients during and after treatment with regard to the above mentioned side-effects. Also, prehabilitative exercise in colon and lung cancer patients was shown as feasible and effective. However, no experience exits with regard to prehabilitation exercise in breast cancer patients.

Conditions

Interventions

TypeNameDescription
BEHAVIORALExerciseThe exercise intervention is an at least 2 weeks lasting (till the day surgery is taking place) 5-times weekly resistance training intervention combined with aerobic exercise (mostly walking).
BEHAVIORALPrehabilitation EducationParticipate will receive a 2 hour group-based prehabilitation class which will be held at the Penn State Cancer Institute, Hershey

Timeline

Start date
2017-10-15
Primary completion
2019-07-01
Completion
2019-07-01
First posted
2018-04-13
Last updated
2020-01-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03498157. Inclusion in this directory is not an endorsement.